Back

When is TAVI futile?

29 August 2017 (11:00 - 11:18)
Organised by:
Congress Presentation Part of: Tough decisions around TAVI Aortic valve surgery ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Catherine M Otto

University of Washington, Seattle (United States of America)

4 More presentations in this session

Presentation thumbnail
Increased gradient post TAVI: what to accept during follow-up
Professor N. Ajmone Marsan (Leiden, NL)
Slides Video
Presentation thumbnail
TAVI with atrial fibrillation: which antithrombotic regimen?
Professor G. Montalescot (Paris, FR)
Slides Video
Presentation thumbnail
Asymptomatic leaflet thrombosis after TAVI: what to do?
Professor F. Neumann (Bad Krozingen, DE)
Slides Video
Presentation thumbnail
Coronary artery disease in TAVI, if and when to treat?
Doctor K. Hayashida (Osaka, JP)
Slides Video

Access the full session

Session thumbnail
Tough decisions around TAVI

The Event

Event poster

ESC Congress 2017

29 August 2017 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Futility risk model development and validation among patients with aortic stenosis treated with transcatheter aortic valve replacement
1 September 2019
thumbnail
Webinar
The year in cardiology 2018
12 December 2018
thumbnail
Congress Session
20 years of TAVI: the remaining unmet needs
23 June 2023
thumbnail
Congress Presentation
Impact of TAVR on GDMT in patients with severe aortic stenosis and HFrEF
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources